ロード中...
Glucagon‐like peptide analogues for type 2 diabetes mellitus
BACKGROUND: Glucagon‐like peptide analogues are a new class of drugs used in the treatment of type 2 diabetes that mimic the endogenous hormone glucagon‐like peptide 1 (GLP‐1). GLP‐1 is an incretin, a gastrointestinal hormone that is released into the circulation in response to ingested nutrients. G...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2011
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486297/ https://ncbi.nlm.nih.gov/pubmed/21975753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006423.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|